Ignite Creation Date:
2025-12-24 @ 6:54 PM
Ignite Modification Date:
2026-05-28 @ 11:07 AM
Study NCT ID:
NCT05687357
Status:
RECRUITING
Last Update Posted:
2023-04-19
First Post:
2022-12-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization: